BridgeBio's Approach To Gene Therapy & Nearing The Clinic With Dr. Eric David
Source: Cell & Gene
BridgeBio's CEO of Gene Therapy, Dr. Eric David, explains the company's gene therapy programs for Canavan disease and congenital adrenal hyperplasia, their manufacturing plans, and the platform underpinning their approach to gene therapy.
This website uses cookies to ensure you get the best experience on our website. Learn more